You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

March 11, 2014

Web Version  |  Share with a colleague

Facebook Like   Twitter Tweet

Today's Headlines

3 steps to help curb saline shortages

Hospital pharmacists are on the frontline of intravenous saline shortages and need to prepare an action plan to ensure patient safety. » Full article

AAP updates off-label drug use

The American Academy of Pediatrics has issued a policy statement updating its recommendations for off-label drug use in the pediatric population. » Full article

Continuing Education

New CPE: MTM essentials for management of CAD and PAD

This month's article is the second in a new year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease.

From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

This month, the professional development activity is “MTM essentials for management of CAD and PAD,” a knowledge-based activity worth up to 2 credits.

The goal of this activity is to review therapeutic strategies pharmacists can utilize to improve patient care in the management of coronary artery disease and peripheral artery disease.

To read and print the article with TEST QUESTIONS, click here.
To proceed to the online exams and earn up to 2 CPE credits, click here to log in.


Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

EDITOR'S PICK

Holes in the drug market place: How do we overcome these obstacles?

Complex diseases present complex challenges for researchers, clinicians, drug manufacturers, and FDA for a variety of reasons. The impact, however, is felt at the patient level, particularly when there are no FDA-approved treatments. » Full article

 

Related Articles

Drug shortages have big impact on patient care

Off-label use of atypical antipsychotics: Lack of evidence for their use in primary insomnia

RESOURCES

Drug Watch

Latest Clinical News

 
Powered by Modern Medicine Advanstar Medical Communications Group